A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
Lead author Dr. S. Ted Treves and colleagues tracked the minimum and maximum administered radiopharmaceutical dose as well as the protocols used to determine appropriate doses. They found variations in maximum dosage for some drugs by a factor of 10 and differences in minimum dose by as much as a factor of 20. Survey results appeared in the June issue of the Journal of Nuclear Medicine.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.